Table 1.
Route | Oral and rectal | Intramuscular, intravenous | Intra-articular, intrabursal, periarticular and other ‘local’ tissue injections |
Recommendation | Only under medical control; cease 1 week precompetition |
Avoid altogether; consider requesting a TUE if use is less than 1 month precompetition | Avoid 3 days precompetition; avoid long-acting formulations (triamcinolone); follow manufacturer’s dose recommendations; retain full medical documentation for AAF investigation purposes |
AAF, adverse analytical finding; TUE, Therapeutic Use Exemption.